Use of standard laboratory methods to obviate routine dithiothreitol treatment of blood samples with daratumumab interference
Paid access
|Oct 2019Authors
N.J. Lintel
House Officer II, University of Nebraska Medical Center, Department of Pathology and Microbiology, Omaha, NE, United States
D.K. Brown
Blood Bank Manager, Nebraska Medicine, Department of Transfusion and Transplant, Omaha, NE, United States
D.T. Schafer
Blood Bank Manager, Nebraska Medicine, Department of Transfusion and Transplant, Omaha, NE, United States
F.M. Tsimba-Chitsva
Technologist III, IRL, American Red Cross, Western Blood Services Division, Midwest Region, Omaha, NE, United States
S.A. Koepsell
University of Nebraska Medical Center, Department of Pathology and Microbiology, Omaha, NE., United States
S.M. Shunkwiler
University of Nebraska Medical Center, Department of Pathology and Microbiology, Omaha, NE., United States
DOI: https://doi.org/10.21307/immunohematology-2019-005 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 22 - 26
Published on: Oct 9, 2019
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2019 N.J. Lintel, D.K. Brown, D.T. Schafer, F.M. Tsimba-Chitsva, S.A. Koepsell, S.M. Shunkwiler, published by American National Red Cross
This work is licensed under the Creative Commons License.